Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,264
Closed -$3.51K 4339
2024
Q2
$3.51K Sell
5,264
-262
-5% -$217 ﹤0.01% 4135
2024
Q1
$7.18K Hold
5,526
﹤0.01% 3920
2023
Q4
$3.17K Hold
5,526
﹤0.01% 4046
2023
Q3
$4.17K Sell
5,526
-3,976
-42% -$3.02K ﹤0.01% 4013
2023
Q2
$6.94K Sell
9,502
-182,576
-95% -$170K ﹤0.01% 4015
2023
Q1
$145K Buy
192,078
+7,240
+4% +$6.72K ﹤0.01% 2806
2022
Q4
$178K Buy
184,838
+1,022
+0.6% +$1.44K ﹤0.01% 2819
2022
Q3
$401K Buy
183,816
+6,653
+4% +$22.9K ﹤0.01% 2598
2022
Q2
$620K Buy
177,163
+48,327
+38% +$181K ﹤0.01% 2380
2022
Q1
$649K Buy
128,836
+1,565
+1% +$7.93K ﹤0.01% 2304
2021
Q4
$798K Sell
127,271
-1,318
-1% -$9K ﹤0.01% 2305
2021
Q3
$1.02M Buy
128,589
+1,483
+1% +$12.2K ﹤0.01% 2220
2021
Q2
$952K Buy
127,106
+61,323
+93% +$428K ﹤0.01% 2264
2021
Q1
$398K Sell
65,783
-5,522
-8% -$42.5K ﹤0.01% 2589
2020
Q4
$407K Buy
71,305
+12,806
+22% +$81.4K ﹤0.01% 2524
2020
Q3
$389K Buy
58,499
+5,824
+11% +$51.9K ﹤0.01% 2404
2020
Q2
$466K Buy
+52,675
New +$151K ﹤0.01% 2377

Other funds holding VXRT

RhumbLine Advisers's VXRT Position: Q3 2024 in Review

RhumbLine Advisers sold out of Vaxart (VXRT) in Q3 2024, closing a stake of 5,264 shares — an estimated $3.51K sold.

RhumbLine Advisers first reported a position in VXRT in Q2 2020 and held it in 17 quarters. The position peaked at $1.02M in Q3 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

  • RhumbLine Advisers reported no remaining Vaxart position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 5,264 Vaxart shares in Q3 2024, an estimated $3.51K.
  • RhumbLine Advisers first reported a position in Vaxart in Q2 2020 and held it in 17 quarters.
  • RhumbLine Advisers's Vaxart position peaked at $1.02M in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.